After long delays, the FDA is expected to decide within weeks whether to authorize Novavax's vaccine.
Novovax COVID-19 vaccine's incubate in flasks at the company research laboratory in Gaithersburg, Md., on May 24, 2022. The company is hoping to find a niche among some of the unvaccinated millions who might agree to their more traditional protein vaccine as a shot. – Americans may soon get a new COVID-19 vaccine option -- shots made with a more tried-and-true technology than today’s versions.
The Novavax vaccine already is used in parts of Europe and multiple other countries, but FDA clearance is a key hurdle. And health experts are closely watching to see if a new tool offers advantages, either in enticing vaccine holdouts or maybe even offering somewhat broader immunity.“What I’ve seen of the Novavax data so far is it’s a really impressive protein vaccine,” said University of Pennsylvania immunologist E. John Wherry.
Novavax, a small biotech company, created the vaccine in its research lab, but the Serum Institute of India, the world’s largest vaccine maker and other factories produce the shots. Like other vaccine makers, Novavax is brewing shots updated to better target omicron. It opened a study in Australia to test how well an omicron-targeted booster revs up immunity in people who initially got Pfizer or Moderna doses.
Indonesia Berita Terbaru, Indonesia Berita utama
Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.
Novavax hopes its COVID shot wins over FDA, vaccine holdoutsGAITHERSBURG, Md. (AP) — Americans may soon get a new COVID-19 vaccine option -- shots made with a more tried-and-true technology than today’s versions. The big question: Why should they care? After long delays, the Food and Drug Administration is expected to decide within weeks whether to authorize Novavax's vaccine.
Baca lebih lajut »
Can Novavax win over vaccine holdouts with its Covid shot?The late entrant into the U.S. vaccination effort uses the same technology seen in vaccines for hepatitis B and shingles, among others.
Baca lebih lajut »
How Long Are You Protected After Getting COVID and Can You Get COVID Twice?For those who test positive for COVID and experience symptoms, how long could they last?
Baca lebih lajut »
Pfizer again asks FDA to authorize Covid vaccine for youngest kidsNEW: Pfizer-BioNTech says it has asked the FDA to authorize its Covid-19 vaccine in children ages 6 months to 4 years — the only group that remains ineligible for vaccination.
Baca lebih lajut »
Pfizer asks FDA to authorize its 3-dose COVID vaccine for children under 5The companies said last month that three doses of the shot were 80% effective at preventing symptomatic COVID-19 and generated a robust immune response in...
Baca lebih lajut »